Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease

BACKGROUND: The previously described and validated Erlangen Score (ES) algorithm enables interpretation of the cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD), ordering them on an ordinal scale: from neurochemically normal (ES = 0) through improbable AD (ES = 1), possible AD (ES = 2...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Alzheimers Res Ther
Glavni autori: Baldeiras, Inês, Santana, Isabel, Leitão, Maria João, Vieira, Daniela, Duro, Diana, Mroczko, Barbara, Kornhuber, Johannes, Lewczuk, Piotr
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6320577/
https://ncbi.nlm.nih.gov/pubmed/30611311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0456-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items